StockData
Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc. (AXSM) stock

AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/30
$134.00−1.95 (-1.43%)

Close on Nov 18, 2026Market cap $7.02BP/E –Yield –

Axsome Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Axsome Therapeutics's market cap was $7.81B on Nov 11, 2026, against $7.62B a year earlier. Over the last 5 years it ranged from $972.09M to $12.59B, with a median of $4.10B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.81B-15.1%
2025Dec 31, 2025$9.19B+124.2%
2024Dec 31, 2024$4.10B+8.8%
2023Dec 29, 2023$3.77B+12.4%
2022Dec 30, 2022$3.35B+135.2%
2021Dec 31, 2021$1.42B-53.2%
2020Dec 31, 2020$3.04B-14.7%
2019Dec 31, 2019$3.57B+4678.8%
2018Dec 31, 2018$74.61M-43.7%
2017Dec 29, 2017$132.53M+2.5%
2016Dec 30, 2016$129.29M+53.3%
2015Dec 31, 2015$84.35M–

More Axsome Therapeutics figures

See a number that looks wrong?